Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berberis vulgaris L. for treatment of opiate withdrawal syndrome in methadone-treated patients
IRCT20180114038356N3Phase 2Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of berberis vulgaris in opioid withdrawal and opioid use disorder (OUD), sponsored by Kerman University of Medical Sciences. Started Apr 2019; status: completed.
02
Drugs
berberis vulgaris
03
Conditions
opioid withdrawalopioid use disorder (OUD)
Beyond the preview
Go deeper on IRCT20180114038356N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180114038356N3.